Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2018-12-01
|
| Series: | Gastroenterology Review |
| Online Access: | https://www.termedia.pl/Empagliflozin-promises-to-bridge-the-gap-between-non-alcoholic-fatty-liver-disease-type-2-diabetes-r-nand-cardiovascular-disease,41,34212,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841548313248137216 |
|---|---|
| author | Dimitrios Patoulias Maria Kalogirou |
| author_facet | Dimitrios Patoulias Maria Kalogirou |
| author_sort | Dimitrios Patoulias |
| collection | DOAJ |
| format | Article |
| id | doaj-art-6fce57bd69cd4cf9a1731960aec2d5c8 |
| institution | Kabale University |
| issn | 1895-5770 1897-4317 |
| language | English |
| publishDate | 2018-12-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Gastroenterology Review |
| spelling | doaj-art-6fce57bd69cd4cf9a1731960aec2d5c82025-01-10T14:06:16ZengTermedia Publishing HouseGastroenterology Review1895-57701897-43172018-12-0113433733910.5114/pg.2018.7981534212Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular diseaseDimitrios PatouliasMaria Kalogirouhttps://www.termedia.pl/Empagliflozin-promises-to-bridge-the-gap-between-non-alcoholic-fatty-liver-disease-type-2-diabetes-r-nand-cardiovascular-disease,41,34212,1,1.html |
| spellingShingle | Dimitrios Patoulias Maria Kalogirou Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease Gastroenterology Review |
| title | Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes,
and cardiovascular disease |
| title_full | Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes,
and cardiovascular disease |
| title_fullStr | Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes,
and cardiovascular disease |
| title_full_unstemmed | Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes,
and cardiovascular disease |
| title_short | Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes,
and cardiovascular disease |
| title_sort | empagliflozin promises to bridge the gap between non alcoholic fatty liver disease type 2 diabetes and cardiovascular disease |
| url | https://www.termedia.pl/Empagliflozin-promises-to-bridge-the-gap-between-non-alcoholic-fatty-liver-disease-type-2-diabetes-r-nand-cardiovascular-disease,41,34212,1,1.html |
| work_keys_str_mv | AT dimitriospatoulias empagliflozinpromisestobridgethegapbetweennonalcoholicfattyliverdiseasetype2diabetesandcardiovasculardisease AT mariakalogirou empagliflozinpromisestobridgethegapbetweennonalcoholicfattyliverdiseasetype2diabetesandcardiovasculardisease |